Biopharma Business

Tag "CureVac"

Lilly signs up to cancer vaccines with CureVac deal

    Lilly signs up to cancer vaccines with CureVac deal

Eli Lilly has signed up CureVac to develop cancer vaccines based on its mRNA technology, in a deal that could potentially be worth more than $2.6 billion to the German

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements